Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cost-effectiveness of risk-reducing surgeries in preventing hereditary breast and ovarian cancer.

Breast (Edinburgh, Scotland) - 1 Apr 2017

Schrauder Michael G, Brunel-Geuder Lisa, Häberle Lothar, Wunderle Marius, Hoyer Juliane, Reis André, Schulz-Wendtland Rüdiger, Beckmann Matthias W, Lux Michael P

Abstract excerpt

OBJECTIVES: Risk-reducing surgeries are a feasible option for mitigating the risk in individuals with inherited susceptibility to cancer, but are the procedures cost-effective in the current health-care system in Germany? This study compared the health-care costs for bilateral risk-reducing mastectomy (BRRM) and risk-reducing (bilateral) salpingo-oophorectomy (RRSO) with cancer treatment costs that could...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to Germany

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Health Care Costs

Share to Hereditary Breast and Ovarian Cancer Syndrome

Share to Ovariectomy

Share to Prophylactic Mastectomy

Share to Risk Reduction Behavior

Share to Ubiquitin-Protein Ligases

Source

Identifiers

PMID: 28214786
DOI: 10.1016/j.breast.2017.02.008

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cost-effectiveness of risk-reducing surgeries in preventing hereditary breast and ovarian cancer.PMID 28214786Read ↗

Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery.Semantic proximity Read ↗

Prophylactic mastectomies in patients with breast cancer and known germline pathogenetic variants: an Austrian registrySemantic proximity Read ↗

Cost-utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA-mutation carriers in Switzerland.Semantic proximity Read ↗

Prophylactic mastectomies and bilateral salpingo-oophorectomies in patients with breast cancer and BRCA mutation: an Austrian registrySemantic proximity Read ↗

Concomitant cancer surgery and risk-reducing surgery for noninvasive breast cancer diagnosed during surveillance for undiagnosed hereditary breast and ovarian cancer (HBOC) syndrome: A case reportSemantic proximity Read ↗

Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review.Semantic proximity Read ↗

Surgical and financial implications of genetic counseling and requests for concurrent prophylactic mastectomy.Semantic proximity Read ↗

Hereditary Women's Cancer: Management and Risk-Reducing Surgery.Semantic proximity Read ↗

Uptake of risk-reducing surgery in BRCA gene carriers in Wales, UK.Semantic proximity Read ↗

Different Patterns of Risk Reducing Decisions in Affected or Unaffected BRCA Pathogenic Variant Carriers.Semantic proximity Read ↗

Risk-reducing mastectomy and salpingo-oophorectomy in women with hereditary breast and ovarian cancer: a single-institute experience following coverage by Japanese national medical insurance.Semantic proximity Read ↗

Breast Cancer Risk Reduction Decisions of the BRCA-Positive Patient: An Observational Study at a Single Institution.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.